NxStage® System One S

System One S offers higher dialysate flow rates designed to provide a wider range of therapy options to meet all of your patients' unique clinical needs.

Therapy Options for Every Lifestyle

Whether your patients are working professionals, students, or retired, System One S offers flexible therapy solutions to fit each of their unique lifestyles.

System One and System One S let patients play an active role in their healthcare by letting them participate in deciding what therapy options work best.

System One S comes with added functionality over the prior generation. With the higher dialysate flow rates offered by System One S, wider ranges of therapy options are now available. Higher dialysate flow rates may also mean the ability to increase clearance, put larger patients on therapy, or decrease treatment time or frequency.

System One S features ergonomic handles and a similar look and feel to the System One Cycler with a few enhancements.

  • Greater ability to increase clearance
    • 18 L/hr dialysate flow rate
    • Added clinical benefits for patients who dialyse 5 or 6 days per week
  • Greater flexibility for your patients
    • Decreased treatment time or frequency may better fit within your patient’s lifestyle
  • Greater patients access to home haemodialysis therapy
    • Larger patients
Risks and Responsibilities

Despite the health benefits that home and more frequent hemodialysis may provide to those with chronic kidney disease, these forms of therapy are not for everyone. Home hemodialysis with the NxStage System One requires a patient and partner who are committed to being trained on and following the guidelines for proper system operation.

The reported benefits of home hemodialysis may not be experienced by all patients.

The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.

Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.

Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep.

Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.

APM2172-ENG Rev. A

Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.

More Info